About us

Partners

THE BETA GROUP

MCI-Forum is part of the Beta Group. Beta with the publications WEHRMEDIZIN UND WEHRPHARMAZIE, WEHRMEDIZINISCHE MONATSSCHRIFT, which is published by the Beta Group on behalf of the German Ministry of Defence, and its team has wide experience in the field of military medicine. The first issue of MCI-Forum appeared in 1986 and the Beta Group can now look back on many years of international contacts. Other journals, such as Arab Medico and Arab Dental originated with the Beta Group and demonstrate the extensive expertise of the Beta Group in the field of international medicine. But Beta also produces books and other publications. Also part of the Beta Group are the web agency beta-web and the seminar company bsbb that has already organised many symposiums and events relating to military medicine and even arranges travel for delegations throughout the world.

Service

News

04/19/2012

seca mBCA 515 – why measure body composition?

Obesity or muscle wasting disease? A patient's body composition data are essential for the diagnosis and treatment of weight-related disorders. Too much fat in the body is …

04/17/2012

Market launch xantasil®: new alginate substitute from Heraeus leaves a lasting impression

Hanau, Germany, 16.04.2012.
xantasil® is a new medium-viscosity addition-curing silicone by Heraeus Dental, which will be launched on the markets in the USA as well as …

04/01/2012

LEICA MICROSYSTEMS INTRODUCES TISSUE IA 2.0* QUANTITATIVE IMAGE ANALYSIS FLUORESCENCE AND BRIGHTFIELD ANALYSIS FOR DIGITAL PATHOLOGY

Wetzlar, Germany, March 30, 2012—
Leica Microsystems announces the release of Tissue IA 2.0, high performance image analysis for discovery research. Combining fluorescence …

03/23/2012

ZOLL X SERIES MONITOR/DEFIBRILLATOR GRANTED 510(K) CLEARANCE BY U.S. FOOD AND DRUG ADMINISTRATION

New Small, Light, Powerful Device Designed for Emergency Medical Services …

03/01/2012

Bavarian Nordic Submits a Marketing Application for its Smallpox Vaccine to the European Medicines Agency

KVISTGAARD, Denmark, March 1, 2012 - Bavarian Nordic A/S (OMX: BAVA) announced today that it has submitted a Marketing Authorization Application (MAA) to the European Medicines …